Inventor · disambiguated record
Yu-Hsing Tu
Also filed as: TU YU H · TU YU-HSING
52 granted patents·27 pending applications·2,350 citations·filing 1999–2025
99Inventor score
Files withTRIS PHARMA INC50TULEX PHARMACEUTICALS INC13MEHTA KETAN10BVM HOLDING CO3AARDVARK THERAPEUTICS INC1
Top patents by PatentIndex Score
79 records- 0199US10933143B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Mar 2, 2021·36 cites·22 claims
- 0299US10668163B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Jun 2, 2020·36 cites·27 claims
- 0399US10172958B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 8, 2019·37 cites·23 claims
- 0499US10086087B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2017·Granted Oct 2, 2018·36 cites·22 claims
- 0599US9675703B2Modified release formulations containing drug - ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·21 claims
- 0699US9675704B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·20 claims
- 0799US9549989B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 24, 2017·40 cites·14 claims
- 0899US9522191B2Modified release formulations containing drug—ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Dec 20, 2016·40 cites·19 claims
- 0999US9198864B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2015·Granted Dec 1, 2015·55 cites·14 claims
- 1099US8883217B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Nov 11, 2014·57 cites·18 claims
- 1199US8790700B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jul 29, 2014·70 cites·29 claims
- 1299US8747902B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jun 10, 2014·70 cites·30 claims
- 1399US8597684B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Dec 3, 2013·77 cites·29 claims
- 1499US8491935B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2012·Granted Jul 23, 2013·95 cites·24 claims
- 1598US10857143B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2019·Granted Dec 8, 2020·45 cites·27 claims
- 1698US10507203B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2018·Granted Dec 17, 2019·42 cites·19 claims
- 1798US9844545B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2017·Granted Dec 19, 2017·43 cites·30 claims
- 1898US9844544B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Dec 19, 2017·46 cites·40 claims
- 1998US9545399B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2016·Granted Jan 17, 2017·50 cites·27 claims
- 2098US9295642B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Mar 29, 2016·61 cites·29 claims
- 2198US9180100B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2015·Granted Nov 10, 2015·55 cites·30 claims
- 2298US9040083B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted May 26, 2015·51 cites·22 claims
- 2398US8999386B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2014·Granted Apr 7, 2015·56 cites·30 claims
- 2498US8956649B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted Feb 17, 2015·51 cites·43 claims
- 2598US8778390B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Jul 15, 2014·62 cites·30 claims
- 2698US8623409B1Clonidine formulationMEHTA KETAN·Filed 2010·Granted Jan 7, 2014·60 cites·28 claims
- 2798US8563033B1Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Oct 22, 2013·67 cites·19 claims
- 2898US8465765B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2012·Granted Jun 18, 2013·71 cites·30 claims
- 2998US8337890B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2010·Granted Dec 25, 2012·79 cites·29 claims
- 3098US8287903B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2011·Granted Oct 16, 2012·88 cites·30 claims
- 3198US8202537B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2011·Granted Jun 19, 2012·94 cites·24 claims
- 3298US8062667B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2007·Granted Nov 22, 2011·119 cites·55 claims
- 3397US11103494B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2020·Granted Aug 31, 2021·5 cites·30 claims
- 3497US11103495B2Methylphenidate extended release chewable tabletTRIS PHARMA INC·Filed 2021·Granted Aug 31, 2021·5 cites·30 claims
- 3596US9867797B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2016·Granted Jan 16, 2018·38 cites·41 claims
- 3696US9408823B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2015·Granted Aug 9, 2016·44 cites·21 claims
- 3796US9180104B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2014·Granted Nov 10, 2015·59 cites·30 claims
- 3896US8512688B2Formulations containing an ionic mineral-ion exchange resin complex and uses thereofMEHTA KETAN·Filed 2012·Granted Aug 20, 2013·68 cites·19 claims
- 3996US8287848B2Formulations containing an ionic mineral-ion exchange resin complex and uses thereofMEHTA KETAN·Filed 2007·Granted Oct 16, 2012·87 cites·24 claims
- 4096US8202542B1Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatingsMEHTA KETAN·Filed 2008·Granted Jun 19, 2012·132 cites·25 claims
- 4195US11433046B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2021·Granted Sep 6, 2022·3 cites·17 claims
- 4294US11911362B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Feb 27, 2024·1 cites·20 claims
- 4393US12343372B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·2 cites·29 claims
- 4493US12214010B2Desmopressin oral compositionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted Feb 4, 2025·2 cites·22 claims
- 4593US11826343B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2023·Granted Nov 28, 2023·1 cites·19 claims
- 4693US11633374B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·2 cites·20 claims
- 4788US12290503B2Compositions and methods for treating epilepsy, seizures and other conditionsTULEX PHARMACEUTICALS INC·Filed 2024·Granted May 6, 2025·0 cites·19 claims
- 4888US11241411B2Benzonatate modified release solid tablets and capsulesTRIS PHARMA INC·Filed 2019·Granted Feb 8, 2022·3 cites·20 claims
- 4987US2023233542A1Methylphenidate Extended Release Chewable TabletTRIS PHARMA INC·Filed 2023·Application pending·0 cites
- 5084US2022168432A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yu-Hsing Tu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →